South & Central America Acne Medication Market Forecast to 2030
South & Central America Acne Medication Market Forecast to 2030 – Regional Analysis – by Therapeutic Class (Retinoids, Benzoyl Peroxide, Antibiotics, Salicylic Acid, and Others), Formulation (Topical Medication and Oral Medication), Type (Prescription Medicine and Over-the-Counter Medicine), Acne Type (Non-Inflammatory Acne and Inflammatory Acne), and Distribution Channel (Pharmacies and Drug Stores, Retail Stores, and E-Commerce)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Upsurge in Need for Organic and Natural Treatments Fuels South & Central America Acne Medication Market
As people are becoming more conscious of the potentially harmful effects of synthetic ingredients and chemicals used in traditional skincare products, the demand for natural and organic alternatives that are deemed to be safer, gentler, and more environmentally friendly is on the rise across the world. Consumers are increasingly seeking products free from harsh chemicals, artificial fragrances, and potentially irritating substances, opting for formulations that harness the power of plant-based ingredients, botanical extracts, essential oils, and other natural compounds known for their skincare benefits. In response to this trend, many skincare brands and manufacturers are developing a wide range of natural and organic acne treatment products that cater to the needs of health-conscious consumers. These products often feature ingredients such as tea tree oil, witch hazel, aloe vera, green tea extract, and salicylic acid derived from natural sources, offering a more holistic and sustainable approach to treating acne without compromising efficacy. In July 2022, MÁDARA, an organic skincare business, introduced two new and natural everyday skincare products—a microbiome-balancing moisturizer and a non-drying face cleanser. The company claims that these products were developed by blending science and nature and were specifically formulated to offer gentle treatment for people of different complexions, who are prone to acne. Both products are made with natural, organic, and vegan ingredients—Northern Juniper Stem Cells, fermented polysaccharides, and lichen and Maté tea extracts—which deal specifically with imperfections, keeping the skin unharmed. Adults and teenagers can both utilize this product. Thus, the increasing preference for natural and organic acne treatment options is expected to continue shaping the future of the South & Central America acne medication market in the coming years.
The shift toward natural and organic acne treatment options is also driven by the increasing stringency of regulatory scrutiny and complications associated with industry standards. Regulatory agencies emphasize ingredient transparency, safety, and sustainability, prompting companies to reformulate their products to meet evolving consumer preferences for cleaner and greener skincare solutions. Thus, as more consumers prioritize natural ingredients and eco-friendly formulations in their skincare routines, the South & Central America acne medication market is expected to experience new growth trends in the coming years.
South & Central America Acne Medication Market Overview
The South & Central America acne medication market is segmented into Argentina, Brazil, Chile, and the Rest of South & Central America. The increased prevalence of acne, influenced by factors such as lifestyle changes, pollution, and stress, is driving the demand for effective acne medications that can provide quick and long-lasting results. Rise in investments and resources allocated to dermatological care, including product development activities and the promotion of effective acne medications. This financial boost enhances research and development efforts, fostering the introduction of advanced formulations and treatment options in the Brazilian market. The improved accessibility to healthcare services and growing skincare awareness further bolsters the demand for acne medications.
South & Central America Acne Medication Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Acne Medication Market Segmentation
The South & Central America acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.
Based on therapeutic class, the South & Central America acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.
In terms of formulation, the South & Central America acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.
By type, the South & Central America acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.
Based on acne type, the South & Central America acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.
In terms of distribution channel, the South & Central America acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.
Based on country, the South & Central America acne medication market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America acne medication market in 2022.
Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, and Viatris Inc are some of the leading companies operating in the South & Central America acne medication market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the South & Central America acne medication market was valued at US$ 525.48 million in 2022 and is expected to reach US$ 674.29 million by 2030, registering a CAGR of 3.2% from 2023 to 2030. Launch of novel drugs and increasing prevalence of severe acne are among the critical factors attributed to the South & Central America acne medication market expansion.
Innovative pharmaceutical developments, including topical and systemic medications, have fundamentally reshaped treatment approaches for acne. In 2022, Sun Pharmaceutical Industries broadened the scope of its collaboration with Cassiopea with respect to an acne treatment. It has signed extension agreements to the license and supply contracts for WINLEVI (clascoterone) cream 1 percent, enlarging the geographical scope to encompass Brazil.
Novel drug launches also include advanced formulations with improved efficacy, enhanced safety profiles, and reduced side effects, catering to the evolving needs of individuals seeking effective acne management. According to a statement released in October 2023 by Bausch Health Companies Inc. and its dermatology business-Ortho Dermatologics-Food and Drug Administration (FDA) approved the New Drug Application for CABTREO topical gel composed of 1.2%, 0.15%, and 3.1% clindamycin phosphate, adapalene, and benzoyl peroxide, respectively. This is a topical treatment indicated for acne vulgaris in patients aged 12 or older. CABTREO is the first and only topical triple combination acne therapy approved by the FDA, which is offered in a fixed-dose form. The company aims to make this gel available for patients in Q1 2024.
The introduction of novel medications, such as retinoids, anti-androgens, and immune modulators, has further expanded the therapeutic options available for healthcare professionals and individuals dealing with acne. The continuous introduction of new drugs stimulates competition, fosters innovation, and encourages research and development investments within the dermatological pharmaceutical industry. The heightened focus on personalized and targeted treatment approaches for treating acne forms a foundation for the advent of novel drugs to improve patient outcomes and satisfaction. Thus, the launch of novel drugs significantly contributes to the progress of the South & Central America acne medication market.
On the contrary, side effects associated with acne medication hampers the growth South & Central America acne medication market.
Based on therapeutic class, the South & Central America acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held 33.5% share of the South & Central America acne medication market in 2022, amassing US$ 176.15 million. It is projected to garner US$ 244.46 million by 2030 to expand at 4.2% CAGR during 2023-2030.
In terms of formulation, the South & Central America acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held 68.6% share of the South & Central America acne medication market in 2022, amassing US$ 360.35 million. It is estimated to garner US$ 480.55 million by 2030 to expand at 3.7% CAGR during 2023-2030.
By type, the South & Central America acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held 65.2% share of South & Central America acne medication market in 2022, amassing US$ 342.73 million. It is predicted to garner US$ 455.32 million by 2030 to expand at 3.6% CAGR during 2023-2030.
Based on acne type, the South & Central America acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held 54.6% share of the South & Central America acne medication market in 2022, amassing US$ 287.09 million. It is projected to garner US$ 375.57 million by 2030 to expand at 3.4% CAGR during 2023-2030.
In terms of distribution channel, the South & Central America acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held 49.7% share of the South & Central America acne medication market in 2022, amassing US$ 261.19 million. It is estimated to garner US$ 353.51 million by 2030 to expand at 3.9% CAGR during 2023-2030.
Based on country, the South & Central America acne medication market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil held 47.9% share of South & Central America acne medication market in 2022, amassing US$ 251.44 million. It is projected to garner US$ 333.37 million by 2030 to expand at 3.6% CAGR during 2023-2030.
Key players operating in the South & Central America acne medication market are Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, and Viatris Inc, among others.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in South & Central America acne medication market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Acne Medication Market Landscape
4.1 PEST Analysis
4.2 Pricing Analysis of Topical and Oral Medication
4.3 Patient Population Undergoing Acne Treatment
5. South & Central America Acne Medication Market – Key Market Dynamics
5.1 South & Central America Acne Medication Market – Key Market Dynamics
5.2 Key Market Drivers
5.2.1 Increasing Prevalence of Severe Acne
5.2.2 Launch of Novel Drugs
5.3 Key Market Restraints
5.3.1 Side Effects Associated with Acne Medication
5.4 Key Market Opportunities
5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
5.5 Future Trends
5.5.1 Upsurge in Need for Organic and Natural Treatments
5.6 Impact of Drivers and Restraints:
6. Acne Medication Market – South & Central America Market Analysis
7. South & Central America Acne Medication Market Analysis – by Therapeutic Class
7.1 Retinoids
7.1.1 Overview
7.1.2 Retinoids: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Benzoyl Peroxide
7.2.1 Overview
7.2.2 Benzoyl Peroxide: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Antibiotics
7.3.1 Overview
7.3.2 Antibiotics: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Salicylic Acid
7.4.1 Overview
7.4.2 Salicylic Acid: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Acne Medication Market Analysis – by Formulation
8.1 Topical Medication
8.1.1 Overview
8.1.2 Topical Medication: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Oral Medication
8.2.1 Overview
8.2.2 Oral Medication: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Acne Medication Market Analysis – by Type
9.1 Prescription Medicine
9.1.1 Overview
9.1.2 Prescription Medicine: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Over-the-Counter Medicine
9.2.1 Overview
9.2.2 Over-the-Counter Medicine: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Acne Medication Market Analysis – by Acne Type
10.1 Non-Inflammatory Acne
10.1.1 Overview
10.1.2 Non-Inflammatory Acne: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Inflammatory Acne
10.2.1 Overview
10.2.2 Inflammatory Acne: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
11. South & Central America Acne Medication Market Analysis – by Distribution Channel
11.1 Pharmacies and Drug Stores
11.1.1 Overview
11.1.2 Pharmacies and Drug Stores: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
11.2 Retail Stores
11.2.1 Overview
11.2.2 Retail Stores: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
11.3 E-Commerce
11.3.1 Overview
11.3.2 E-Commerce: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12. South & Central America Acne Medication Market – Country Analysis
12.1 South & Central America
12.1.1 South & Central America: Acne Medication Market – Revenue and Forecast Analysis – by Country
12.1.1.1 Brazil
12.1.1.2 Brazil: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.2.1 Brazil: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.2.2 Brazil: Acne Medication Market Breakdown, by Formulation
12.1.1.2.3 Brazil: Acne Medication Market Breakdown, by Type
12.1.1.2.4 Brazil: Acne Medication Market Breakdown, by Acne Type
12.1.1.2.5 Brazil: Acne Medication Market Breakdown, by Distribution Channel
12.1.1.3 Argentina
12.1.1.4 Argentina: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.4.1 Argentina: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.4.2 Argentina: Acne Medication Market Breakdown, by Formulation
12.1.1.4.3 Argentina: Acne Medication Market Breakdown, by Type
12.1.1.4.4 Argentina: Acne Medication Market Breakdown, by Acne Type
12.1.1.4.5 Argentina: Acne Medication Market Breakdown, by Distribution Channel
12.1.1.5 Rest of South & Central America
12.1.1.6 Rest of South & Central America: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.6.1 Rest of South & Central America: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.6.2 Rest of South & Central America: Acne Medication Market Breakdown, by Formulation
12.1.1.6.3 Rest of South & Central America: Acne Medication Market Breakdown, by Type
12.1.1.6.4 Rest of South & Central America: Acne Medication Market Breakdown, by Acne Type
12.1.1.6.5 Rest of South & Central America: Acne Medication Market Breakdown, by Distribution Channel
13. South & Central America Acne Medication Market- Industry Landscape
13.1 Overview
13.2 Growth Strategies in Acne Medication Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
13.5 Product Offered by Farmapiel vs Other Companies Acne Products
14. Company Profiles
14.1 Teva Pharmaceutical Industries Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Almirall SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Johnson & Johnson
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Sun Pharmaceutical Industries Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bausch Health Companies Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Galderma SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Pfizer Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 GSK Plc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Viatris Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The the Reporting Teams
15.2 Glossary of Terms
Table 1. South & Central America Acne Medication Market Segmentation
Table 2. Topical Medication
Table 3. Oral Medication
Table 4. Patient Population undergoing Acne Treatment from 2020-2023
Table 5. South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Therapeutic Class
Table 6. South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Formulation
Table 7. South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 8. South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Acne Type
Table 9. South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Distribution Channel
Table 10. Brazil: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 11. Brazil: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 12. Brazil: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 13. Brazil: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 14. Brazil: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 15. Argentina: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 16. Argentina: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 17. Argentina: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 18. Argentina: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 19. Argentina: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 20. Rest of South & Central America: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 21. Rest of South & Central America: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 22. Rest of South & Central America: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 23. Rest of South & Central America: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 24. Rest of South & Central America: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 25. Recent Organic Growth Strategies in Acne Medication Market
Table 26. Recent Inorganic Growth Strategies in the Acne Medication Market
Table 27. Glossary of Terms, Acne Medication Market
Figure 1. South & Central America Acne Medication Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Acne Medication Market Revenue (US$ Million), 2022-2030
Figure 5. South & Central America Acne Medication Market Share (%) – by Therapeutic Class (2022 and 2030)
Figure 6. Retinoids: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Benzoyl Peroxide: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Antibiotics: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Salicylic Acid: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. South & Central America Acne Medication Market Share (%) – by Formulation (2022 and 2030)
Figure 12. Topical Medication: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Oral Medication: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. South & Central America Acne Medication Market Share (%) – by Type (2022 and 2030)
Figure 15. Prescription Medicine: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Over-the-Counter Medicine: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. South & Central America Acne Medication Market Share (%) – by Acne Type (2022 and 2030)
Figure 18. Non-Inflammatory Acne: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Inflammatory Acne: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. South & Central America Acne Medication Market Share (%) – by Distribution Channel (2022 and 2030)
Figure 21. Pharmacies and Drug Stores: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Retail Stores: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. E-Commerce: South & Central America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. South & Central America: Acne Medication Market, by Key Country – Revenue (2022) (US$ Million)
Figure 25. South & Central America: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 26. Brazil: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 27. Argentina: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. Rest of South & Central America: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. Growth Strategies in Acne Medication Market
The List of Companies – South and Central America Acne Medication Market
1. Teva Pharmaceutical Industries Ltd
2. Almirall SA
3. Johnson & Johnson
4. Sun Pharmaceutical Industries Ltd
5. Bausch Health Companies Inc
6. Galderma SA
7. Pfizer Inc
8. GSK Plc
9. Viatris Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.